Aurobindo Pharma Ltd on Wednesday 11 September announced that its new injectable facility in Andhra Pradesh has secured its first product approval from the US...
Aurobindo Pharma subsidiary Eugia Pharma’s injectable plant in Telangana was classified by the US Food and Drug Administration (USFDA) in an establishment inspection report as...
Shares of Aurobindo Pharma slumped 3% on 27 May after the company’s Telangana facility received an Official Action Indicated classification from the US Food and Drug...
Shares of Aurobindo Pharma were trading in the green and 2% higher on 30 November after the company’s wholly-owned subsidiary received final approval from the...